Alivus Life Sciences (NSE:ALIVUS) EPS (Basic) : ₹36.05 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alivus Life Sciences EPS (Basic)?

Alivus Life Sciences's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ₹11.18. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹36.05.

Alivus Life Sciences's EPS (Diluted) for the three months ended in Dec. 2024 was ₹11.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹35.93.

Alivus Life Sciences's EPS without NRI for the three months ended in Dec. 2024 was ₹11.14. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 35.93.

During the past 12 months, Alivus Life Sciences's average EPS without NRIGrowth Rate was -15.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 10.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Alivus Life Sciences's highest 3-Year average EPS without NRI Growth Rate was 14.20% per year. The lowest was 10.20% per year. And the median was 14.20% per year.

Alivus Life Sciences EPS (Basic) Historical Data

The historical data trend for Alivus Life Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alivus Life Sciences EPS (Basic) Chart

Alivus Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

25.55

28.69

35.63

38.11

38.43

Alivus Life Sciences Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															9.69	7.99	9.10	7.78	11.18

Alivus Life Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Alivus Life Sciences's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(4708.88	-	0)	/	122.527
	=	38.43

Alivus Life Sciences's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(1369.6	-	0)	/	122.504
	=	11.18

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹36.05

Alivus Life Sciences (NSE:ALIVUS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Alivus Life Sciences EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Alivus Life Sciences's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Alivus Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alivus Life Sciences Ltd (NSE:ALIVUS) » Definitions » EPS (Basic)

Traded in Other Exchanges

543322:India

Address

470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099

Website

https://www.alivus.com

Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Alivus Life Sciences Headlines

No Headlines